CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $356,328
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$356,328. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-14 | Schoen Eric Chief Financial Officer | Purchase | +10,000 | $1.06 | $11K | 10,000 |
| 2018-10-31 | Schoen Eric Chief Financial Officer | Grant or award · Common Stock (1) | +50,000 | $1.18 | $59K | 50,000 |
| 2018-10-03 | ARMISTICE CAPITAL, LLC 10% owner | Sale | −512,660 | $1.31 | $672K | 1,651,340 |
| 2018-10-03 | ARMISTICE CAPITAL, LLC 10% owner | Sale | −0 | 0 | ||
| 2018-10-03 | ARMISTICE CAPITAL, LLC 10% owner | Sale | −0 | 0 | ||
| 2018-09-28 | BARBIER REMI CEO, Chairman of the Board | Grant or award · Stock Options(1) | +60,000 | $1.01 | $61K | 60,000 |
| 2018-09-27 | ROBERTSON SANFORD Director | Purchase | +37,817 | $1.05 | $40K | 162,623 |
| 2018-09-26 | ROBERTSON SANFORD Director | Purchase | +30,992 | $1.05 | $33K | 124,806 |
| 2018-09-25 | ROBERTSON SANFORD Director | Purchase | +21,420 | $1.00 | $21K | 93,814 |
| 2018-09-24 | ROBERTSON SANFORD Director | Purchase | +9,771 | $0.96 | $9K | 72,394 |
| 2018-09-14 | GUSSIN ROBERT Z Director | Grant or award · Stock Options(1) | +15,000 | $0.95 | $14K | 128,468 |
| 2018-09-14 | O DONNELL MICHAEL J Director | Grant or award · Stock Options(1) | +10,000 | $0.95 | $10K | 94,446 |
| 2018-09-14 | Ramasastry Saira Director | Grant or award · Stock Options(1) | +15,000 | $0.95 | $14K | 94,991 |
| 2018-09-14 | ROBERTSON SANFORD Director | Grant or award · Stock Options(1) | +15,000 | $0.95 | $14K | 128,472 |
| 2018-09-14 | SCANNON PATRICK J MD PHD Director | Grant or award · Stock Options(1) | +10,000 | $0.95 | $10K | 107,400 |
| 2018-09-14 | FRIEDMANN NADAV Chief Sientific Officer | Grant or award · Stock Options(1) | +50,000 | $0.95 | $48K | 600,993 |
| 2018-08-20 | ARMISTICE CAPITAL, LLC 10% owner | Sale | −8,000 | $0.91 | $7K | 2,164,000 |
| 2018-08-20 | ARMISTICE CAPITAL, LLC 10% owner | Sale | −0 | 2,164,000 | ||
| 2018-08-20 | ARMISTICE CAPITAL, LLC 10% owner | Sale | −0 | 2,164,000 | ||
| 2018-08-17 | ARMISTICE CAPITAL, LLC 10% owner | Sale | −48,000 | $0.95 | $46K | 2,172,000 |
Page 10 of 17 · 324 trades